부산대학교 도서관

Biswas, Dhruva; Liu, Yun-Hsin; Herrero, Javier; Wu, Yin; Moore, David A.; Karasaki, Takahiro; Grigoriadis, Kristiana; Lu, Wei-Ting; Veeriah, Selvaraju; Naceur-Lombardelli, Cristina; Magno, Neil; Ward, Sophia; Frankell, Alexander M.; Hill, Mark S.; Colliver, Emma; de Carné Trécesson, Sophie; East, Philip; Malhi, Aman; Snell, Daniel M.; O'Neill, Olga; Leonce, Daniel; Mattsson, Johanna, 1985; Lindberg, Amanda; Micke, Patrick; Moldvay, Judit; Megyesfalvi, Zsolt; Dome, Balazs; Fillinger, János; Nicod, Jerome; Downward, Julian; Szallasi, Zoltan; Hackshaw, Allan; Jamal-Hanjani, Mariam; Kanu, Nnennaya; Birkbak, Nicolai J.; Swanton, Charles

Nature Cancer. 6(1):86-101

Dijkstra KK; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Oncode Institute, Utrecht, the Netherlands. Electronic address: k.dijkstra@nki.nl.; Vendramin R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Tumor ImmunoGenomics and Immunosurveillance Laboratory, University College London Cancer Institute, University College London, London, UK.; Karagianni D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Immunology Unit, Immune Regulation and Tumor Immunotherapy Group, Research Department of Haematology, University College London Cancer Institute, London, UK.; Witsen M; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.; Gálvez-Cancino F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Immunology Unit, Immune Regulation and Tumor Immunotherapy Group, Research Department of Haematology, University College London Cancer Institute, London, UK; Immune Regulation Laboratory, Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Foster KA; Cancer Immunology Unit, Immune Regulation and Tumor Immunotherapy Group, Research Department of Haematology, University College London Cancer Institute, London, UK.; Barbè V; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Hynds RE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Epithelial Cell Biology in ENT Research (EpiCENTR) Group, Developmental Biology and Cancer Department, Great Ormond Street UCL Institute of Child Health, University College London, London, UK.; Pearce DR; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Martínez-Ruiz C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Black JRM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Augustine M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Tumor ImmunoGenomics and Immunosurveillance Laboratory, University College London Cancer Institute, University College London, London, UK; Division of Medicine, University College London, London, UK.; Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Department of Cellular Pathology, University College London Hospital, London, UK.; Liu LL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Saghafinia S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; van de Haar J; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.; Veeriah S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Naceur-Lombardelli C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Toncheva A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Bola SK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Immunology Unit, Immune Regulation and Tumor Immunotherapy Group, Research Department of Haematology, University College London Cancer Institute, London, UK.; Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals, London, UK.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Tumor ImmunoGenomics and Immunosurveillance Laboratory, University College London Cancer Institute, University College London, London, UK.; Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Pre-Cancer Immunology Laboratory, University College London Cancer Institute, London, UK.; Chain B; University College London Cancer Institute, London, UK; Division of Infection and Immunity, University College London, London, UK.; Quezada SA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Cancer Immunology Unit, Immune Regulation and Tumor Immunotherapy Group, Research Department of Haematology, University College London Cancer Institute, London, UK. Electronic address: s.quezada@ucl.ac.uk.; Voest EE; Department of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Electronic address: e.voest@nki.nl.; Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, UK; Department of Medical Oncology, University College London Hospitals, London, UK. Electronic address: charles.swanton@crick.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Thoracic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.; Abbott CW; Personalis Inc., Fremont, CA, USA.; Li B; Personalis Inc., Fremont, CA, USA.; Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Al Bakir M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK.; Liu WK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Pawlik P; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, UK.; Marinelli D; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Shutkever O; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Murphy C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Liu LY; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Grieco C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Grimes K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Navarro FCP; Personalis Inc., Fremont, CA, USA.; Pyke RM; Personalis Inc., Fremont, CA, USA.; Bartha G; Personalis Inc., Fremont, CA, USA.; Keough KC; Personalis Inc., Fremont, CA, USA.; Dea S; Personalis Inc., Fremont, CA, USA.; Ravi N; Personalis Inc., Fremont, CA, USA.; Lyle J; Personalis Inc., Fremont, CA, USA.; Harris J; Personalis Inc., Fremont, CA, USA.; Brown KD; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Blackhall FH; The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Hassani F; University Hospitals of Leicester NHS Trust, Leicester, UK.; Fennell DA; University Hospitals of Leicester NHS Trust, Leicester, UK; University of Leicester, Leicester, UK.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.; Shaw JA; University of Leicester, Leicester, UK; NIHR Leicester Biomedical Research Centre, Leicester, UK.; Abbosh C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; AstraZeneca, Cambridge, UK.; Hackshaw A; Cancer Research UK, UCL Clinical Trials Centre, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Early Cancer Institute, University of Cambridge, Cambridge, UK.; Boyle SM; Personalis Inc., Fremont, CA, USA.; Chen RO; Personalis Inc., Fremont, CA, USA.; Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK. Electronic address: charles.swanton@crick.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Gimeno-Valiente F; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Castignani C; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Larose Cadieux E; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK.; Mensah NE; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Medical Genomics, University College London Cancer Institute, London, UK.; Liu X; Medical Genomics, University College London Cancer Institute, London, UK.; Chen K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Thoracic Oncology Institute, Peking University People's Hospital, Beijing, China.; Department of Thoracic Surgery, Peking University People's Hospital, Beijing, China.; Chervova O; Medical Genomics, University College London Cancer Institute, London, UK.; Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Weeden CE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Richard C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Lai S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Watkins TBK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Stavrou G; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Usaite I; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Marinelli D; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Saghafinia S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Dhami P; Genomics Research Platform, R&D Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Vaikkinen H; Genomics Research Platform, R&D Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Steif J; Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.; Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Hynds RE; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Hirst M; Department of Microbiology and Immunology, Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada.; Hiley C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Feber A; Division of Surgery and Interventional Science Medical Genomics, University College London, London, UK.; Centre for Molecular Pathology, Royal Marsden Hospital Trust, London, UK.; Translational Epigenetic, Molecular Pathology, The Institute of Cancer Research, London, UK.; Deniz Ö; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.; QMUL Centre for Epigenetics, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Beck S; Medical Genomics, University College London Cancer Institute, London, UK.; Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium.; Integrative Cancer Genomics Laboratory, Department of Oncology, KU Leuven, Leuven, Belgium.; Tanić M; Medical Genomics, University College London Cancer Institute, London, UK.; Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia.; Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK. pvanloo@mdanderson.org.; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pvanloo@mdanderson.org.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. pvanloo@mdanderson.org.; Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. n.kanu@ucl.ac.uk.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Robert E. Hynds; Ariana Huebner; David R. Pearce; Mark S. Hill; Ayse U. Akarca; David A. Moore; Sophia Ward; Kate H. C. Gowers; Takahiro Karasaki; Maise Al Bakir; Gareth A. Wilson; Oriol Pich; Carlos Martínez-Ruiz; A. S. Md Mukarram Hossain; Simon P. Pearce; Monica Sivakumar; Assma Ben Aissa; Eva Grönroos; Deepak Chandrasekharan; Krishna K. Kolluri; Rebecca Towns; Kaiwen Wang; Daniel E. Cook; Leticia Bosshard-Carter; Cristina Naceur-Lombardelli; Andrew J. Rowan; Selvaraju Veeriah; Kevin Litchfield; Philip A. J. Crosbie; Caroline Dive; Sergio A. Quezada; Sam M. Janes; Mariam Jamal-Hanjani; Teresa Marafioti; TRACERx consortium; Nicholas McGranahan; Charles Swanton

Nature Communications, Vol 15, Iss 1, Pp 1-21 (2024)

Hessey, S.; Bunkum, A.; Grigoriadis, K.; Huebner, A.; Liu, W.K.; Lombardelli, C.; Veeriah, S.; Ward, S.; Zaccaria, S.; McGranahan, N.; Swanton, C.; Jamal-Hanjani, M.

ESMO Open. 9

Koh, K.; Liu, W.K.; Al-Sawaf, O.; Richard, C.; Haase, K.; Scott, R.; Veeriah, S.; Lombardelli, C.; Furlani, I.; Macrae, J.; Swanton, C.; Jamal-Hanjani, M.

ESMO Open. 9

Scott, R.; Al-Sawaf, O.; Koh, K.; Haase, K.; Richard, C.; Lombardelli, C.; Veeriah, S.; Kanu, N.; Swanton, C.; Jamal-Hanjani, M.

ESMO Open. 9

Veeriah, Vivek; van Seijen, Harm; Sutton, Richard S.

Proceedings of the 16th Conference on Autonomous Agents and MultiAgent Systems. :556-564

Kearney, Alex; Veeriah, Vivek; Travnik, Jaden; Pilarski, Patrick M.; Sutton, Richard S.

Ng KW; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.; Boumelha J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Enfield KSS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Almagro J; Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK.; Cha H; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Karasaki T; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Moore DA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.; Salgado R; Department of Pathology, ZAS Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, Melbourne, Queensland, Australia.; Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Young G; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.; Bioinformatics and Biostatistics Facility, The Francis Crick Institute, London, UK.; Molina-Arcas M; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Anastasiou P; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.; Fendler A; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Au L; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Shepherd STC; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Puttick C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Kim H; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Shim S; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.; Faulkner N; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK.; Attig J; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.; Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Magno N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Ward S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Advanced Sequencing Facility, The Francis Crick Institute, London, UK.; Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Hill MS; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cook DE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark.; Behrens A; Adult Stem Cell Laboratory, The Francis Crick Institute, London, UK.; Cancer Stem Cell Laboratory, Institute of Cancer Research, London, UK.; Division of Cancer, Department of Surgery and Cancer, Imperial College, London, UK.; CRUK Convergence Science Centre, Imperial College, London, UK.; Yousaf N; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Lung Unit, The Royal Marsden Hospital, London, UK.; Popat S; Lung Unit, The Royal Marsden Hospital, London, UK.; Division of Clinical Studies, The Institute of Cancer Research, London, UK.; Hackshaw A; Cancer Research UK and University College London Cancer Trials Centre, London, UK.; Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Litchfield K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Tumour Immunogenomics and Immunosurveillance Laboratory, University College London Cancer Institute, London, UK.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.; Larkin J; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK.; Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Health Sciences and Technology, Samsung Advanced Institute of Health Sciences and Technology, Sungkyunkwan University, Seoul, Republic of Korea.; Turajlic S; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Renal and Skin Units, The Royal Marsden Hospital, London, UK.; Melanoma and Kidney Cancer Team, The Institute of Cancer Research, London, UK.; Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.; Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK. julian.downward@crick.ac.uk.; Kassiotis G; Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK. george.kassiotis@crick.ac.uk.; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, UK. george.kassiotis@crick.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; In Process

Kearney, Alex; Veeriah, Vivek; Travnik, Jaden B.; Sutton, Richard S.; Pilarski, Patrick M.

Kittel, J.; Bailey, C.; Hessey, S.; Richard, C.; Lombardelli, C.; Veeriah, S.; Kanu, N.; Jamal-Hanjani, M.; Swanton, C.

ESMO Open. 8(1)

Kilim O; Pipek O; Sztupinszki Z; Diossy M; Prosz A; Naceur-Lombardelli C; Veeriah S; Moore D; Jamal-Hanjani M; Hackshaw A; Fillinger J; Moldvay J; Csabai I; Swanton C; Szallasi Z

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Veeriah, Vivek; Zhang, Shangtong; Sutton, Richard S.

Veeriah, Vivek; Pilarski, Patrick M.; Sutton, Richard S.

Frankell, AM; Dietzen, M; Al Bakir, M; Lim, EL; Karasaki, T; Ward, S; Veeriah, S; Colliver, E; Huebner, A; Bunkum, A; Hill, MS; Grigoriadis, K; Moore, DA; Black, JRM; Liu, WK; Thol, K; Pich, O; Watkins, TBK; Naceur-Lombardelli, C; Cook, DE; Salgado, R; Wilson, GA; Bailey, C; Angelova, M; Bentham, R; Martínez-Ruiz, C; Abbosh, C; Nicholson, AG; Le Quesne, J; Biswas, D; Rosenthal, R; Puttick, C; Hessey, S; Lee, C; Prymas, P; Toncheva, A; Smith, J; Xing, W; Nicod, J; Price, G; Kerr, KM; Naidu, B; Middleton, G; Blyth, KG; Fennell, DA; Forster, MD; Lee, SM; Falzon, M; Hewish, M; Shackcloth, MJ; Lim, E; Benafif, S; Russell, P; Boleti, E; Krebs, MG; Lester, JF; Papadatos-Pastos, D; Ahmad, T; Thakrar, RM; Lawrence, D; Navani, N; Janes, SM; Dive, C; Blackhall, FH; Summers, Y; Cave, J; Marafioti, T; Herrero, J; Quezada, SA; Peggs, KS; Schwarz, RF; Van Loo, P; Miedema, DM; Birkbak, NJ; Hiley, CT; Hackshaw, A; Zaccaria, S; Bajaj, A; Nakas, A; Sodha-Ramdeen, A; Ang, K; Tufail, M; Chowdhry, MF; Scotland, M; Boyles, R; Rathinam, S; Wilson, C; Marrone, D; Dulloo, S; Matharu, G; Shaw, JA; Riley, J; Primrose, L; Cheyne, H; Khalil, M; Richardson, S; Cruickshank, T; Gilbert, K

Maise Al Bakir; James L. Reading; Samuel Gamble; Rachel Rosenthal; Imran Uddin; Andrew Rowan; Joanna Przewrocka; Amber Rogers; Yien Ning Sophia Wong; Amalie K. Bentzen; Selvaraju Veeriah; S

Nature, Nature. 639(8056):1052-1059

Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Bartha G; Personalis Inc., Fremont, CA, USA.; Abbott CW; Personalis Inc., Fremont, CA, USA.; Boyle SM; Personalis Inc., Fremont, CA, USA.; Karasaki T; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Thoracic Surgery, Respiratory Center, Toranomon Hospital, Tokyo, Japan.; Li B; Personalis Inc., Fremont, CA, USA.; Chen R; Personalis Inc., Fremont, CA, USA.; Harris J; Personalis Inc., Fremont, CA, USA.; Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Colopi M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bakir MA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Liu WK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Lyle J; Personalis Inc., Fremont, CA, USA.; Navarro FCP; Personalis Inc., Fremont, CA, USA.; Northcott J; Personalis Inc., Fremont, CA, USA.; Pyke RM; Personalis Inc., Fremont, CA, USA.; Hill MS; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Thol K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Huebner A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bailey C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Colliver EC; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Grigoriadis K; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Pawlik P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.; Marinelli D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Shutkever OG; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Murphy C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Sivakumar M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Shaw JA; Leicester NIHR BRC & University of Leicester, Leicester, UK.; Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, UK.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Oncology, University College London Hospitals, London, UK.; Frankell AM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK.; Chen RO; Personalis Inc., Fremont, CA, USA.; Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. Charles.swanton@crick.ac.uk.; Cancer Evolution and Genome Instability Laboratory., The Francis Crick Institute, London, UK. Charles.swanton@crick.ac.uk.; Department of Oncology, University College London Hospitals, London, UK. Charles.swanton@crick.ac.uk.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Biswas D; Birkbak NJ; Rosenthal R; Hiley CT; Lim EL; Papp K; Boeing S; Krzystanek M; Djureinovic D; La Fleur L; Greco M; Döme B; Fillinger J; Brunnström H; Wu Y; Moore DA; Skrzypski M; Abbosh C; Litchfield K; Al Bakir M; Watkins TBK; Veeriah S; Wilson GA; Jamal-Hanjani M; Moldvay J; Botling J; Chinnaiyan AM; Micke P; Hackshaw A; Bartek J; Csabai I; Szallasi Z; Herrero J; McGranahan N; Swanton C; TRACERx Consortium

TRACERx Consortium 2019, ' A clonal expression biomarker associates with lung cancer mortality ', Nature Medicine, vol. 25, no. 10, pp. 1540-1548 . https://doi.org/10.1038/s41591-019-0595-z
Biswas, D, Birkbak, N J, Rosenthal, R, Hiley, C T, Lim, E L, Papp, K, Boeing, S, Krzystanek, M, Djureinovic, D, La Fleur, L, Greco, M, Döme, B, Fillinger, J, Brunnström, H, Wu, Y, Moore, D A, Skrzypski, M, Abbosh, C, Litchfield, K, Al Bakir, M, Watkins, T B K, Veeriah, S, Wilson, G A, Jamal-Hanjani, M, Moldvay, J, Botling, J, Chinnaiyan, A M, Micke, P, Hackshaw, A, Bartek, J, Csabai, I, Szallasi, Z, Herrero, J, McGranahan, N, Swanton, C & TRACERx Consortium 2019, 'A clonal expression biomarker associates with lung cancer mortality', Nature Medicine, vol. 25, no. 10, pp. 1540-1548. https://doi.org/10.1038/s41591-019-0595-z